Background: Successful control programs have impeded local malaria transmission in almost all Gulf Cooperation Council (GCC) countries: Qatar, Bahrain, Kuwait, Oman, the United Arab Emirates (UAE) and Saudi Arabia. Nevertheless, a prodigious influx of imported malaria via migrant workers sustains the threat of local transmission. Here we examine the origin of imported malaria in Qatar, assess genetic diversity and the prevalence of drug resistance genes in imported Plasmodium falciparum, and finally, address the potential for the reintroduction of local transmission. Methods: This study examined imported malaria cases reported in Qatar, between 2013 and 2016. We focused on P. falciparum infections and estimated both total parasite and gametocyte density, using qPCR and qRT-PCR, respectively. We also examined ten neutral microsatellites and four genes associated with drug resistance, Pfmrp1, Pfcrt, Pfmdr1, and Pfkelch13, to assess the genetic diversity of imported P. falciparum strains, and the potential for propagating drug resistance genotypes respectively. Results: The majority of imported malaria cases were P. vivax, while P. falciparum and mixed species infections (P. falciparum / P. vivax) were less frequent. The primary origin of P. vivax infection was the Indian subcontinent, while P. falciparum was mostly presented by African expatriates. Imported P. falciparum strains were highly diverse, carrying multiple genotypes, and infections also presented with early-and late-stage gametocytes. We observed a high prevalence of mutations implicated in drug resistance among these strains, including novel SNPs in Pfkelch13. Conclusions: The influx of genetically diverse P. falciparum, with multiple drug resistance markers and a high capacity for gametocyte production, represents a threat for the reestablishment of drug-resistant malaria into GCC countries. This scenario highlights the impact of mass international migration on the reintroduction of malaria to areas with absent or limited local transmission.
Background Successful malaria control programs have interrupted local malaria transmission in almost all the Gulf Cooperation Council (GCC) countries. However, a massive influx of imported malaria via migrant workers from endemic areas sustains a threat for the re-introduction of local transmission. Here we examined the origin of imported malaria into one of the GCC countries (Qatar) and assessed the extent of genetic diversity, and carriage of drug resistance genes of imported Plasmodium falciparum and it’s potential to re-introduce the disease. Methods We examined imported malaria reported in Qatar, between 2013 and 2016. We focused on P. falciparum infections and estimated total parasite and gametocyte density using qPCR and qRT-PCR, respectively. In addition, we examined ten neutral microsatellites and four drug resistance genes, Pfmrp1, Pfcrt, Pfmdr1 and Pfkelch13 , to assess the extent of diversity of imported P. falciparum and its potential carriage of drug resistance genotypes respectively. Results The majority of imported malaria comprised P. vivax , while P. falciparum and mixed species infections ( P. falciparum /P. vivax ) were less frequent. The main origin of P. vivax was the Indian subcontinent, while P. falciparum was most apparent among expatriates from Africa. Imported P. falciparum was highly diverse carrying multiple genotypes as well as early and late gametocytes. We observed a high prevalence of SNPs implicated in drug resistance among imported P. falciparum , with some novel SNPs in Pfkelch13 . Conclusions The high influx of genetically diverse P. falciparum, with multiple drug resistance marker gene mutations and high capacity of producing gametocytes, sustains threat for re-introduction of drug resistant malaria into GCC countries. This scenario highlights the impact of current globalisation of movement of humans in reintroducing malaria infections to areas targeted for elimination.
Background Successful malaria control programs have interrupted local malaria transmission in almost all the Gulf Cooperation Council (GCC) countries. However, a massive influx of imported malaria via migrant workers from endemic areas sustains a threat for the re-introduction of local transmission. Here we examined the origin of imported malaria into one of the GCC countries (Qatar) and assessed the extent of genetic diversity, and carriage of drug resistance genes of imported Plasmodium falciparum and it’s potential to re-introduce the disease. Methods We examined imported malaria reported in Qatar, between 2013 and 2016. We focused on P. falciparum infections and estimated total parasite and gametocyte density using qPCR and qRT-PCR, respectively. In addition, we examined ten neutral microsatellites and four drug resistance genes, Pfmrp1, Pfcrt, Pfmdr1 and Pfkelch13 , to assess the extent of diversity of imported P. falciparum and its potential carriage of drug resistance genotypes respectively. Results The majority of imported malaria comprised P. vivax , while P. falciparum and mixed species infections ( P. falciparum /P. vivax ) were less frequent. The main origin of P. vivax was the Indian subcontinent, while P. falciparum was most apparent among expatriates from Africa. Imported P. falciparum was highly diverse carrying multiple genotypes as well as early and late gametocytes. We observed a high prevalence of SNPs implicated in drug resistance among imported P. falciparum , with some novel SNPs in Pfkelch13 . Conclusions The high influx of genetically diverse P. falciparum, with multiple drug resistance marker gene mutations and high capacity of producing gametocytes, sustains threat for re-introduction of drug resistant malaria into GCC countries. This scenario highlights the impact of current globalisation of movement of humans in reintroducing malaria infections to areas targeted for elimination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.